Download PDF
Onkologie up2date 2019; 1(02): 127-141
DOI: 10.1055/a-0849-2516
Tumoren der Atemwege
Georg Thieme Verlag KG Stuttgart · New York

Modernes Management des Pancoast-Tumors

Modern Management of Pancoast Tumour
Alessandro Marra
Further Information

Publication History

Publication Date:
15 May 2019 (online)

    Permissions and Reprints All articles of this category

Zusammenfassung

Der Pancoast-Tumor (Sulcus-superior-Tumor) ist eine Sonderform des Lungenkarzinoms mit Infiltration der oberen Thoraxapertur, die durch Schulterschmerz und eventuell Horner-Syndrom klinisch auffällig wird. Die häufig verspätete Diagnose und die komplexe Anatomie der Region stellen eine Herausforderung für die Therapeuten dar. Dieser Beitrag schildert, wie moderne Diagnostik und multimodale Behandlung die Prognose der Erkrankung positiv beeinflussen können.

Abstract

Pancoast or superior pulmonary sulcus tumour is a subset of lung carcinoma that invades the structures of the thoracic inlet – first ribs, distal roots of the brachial plexus, stellate ganglion, vertebrae, and subclavian vessels. The first symptom is usually shoulder pain; consequently, most patients are initially treated for osteoarthritis. Late diagnosis is common. Success of therapy depends on an accurate staging: standard imaging with CT scan of the chest, PET-CT scan, brain MRI are needed to rule out distant metastases, endobronchial ultrasound-guided needle biopsy (EBUS-TBNA) or mediastinoscopy are mandatory for reliable nodal staging. An MRI of the thoracic inlet allows to clearly define the boundaries of local invasion. Modern management of Pancoast tumour includes induction concurrent chemoradiotherapy followed by surgical resection. As compared with historical series treated by preoperative radiation, a trimodally approach did enhance complete resection rates and perhaps long-term survival – from about 30% 5-year survival rate to 60% in R0-resected patients. In patients who have unresectable but non-metastatic Pancoast tumours and appropriate performance status, definitive concurrent chemoradiotherapy and radiotherapy are recommended options.

Kernaussagen

  • Der Pancoast-Tumor ist ein Lungenkarzinom mit Infiltration der oberen Thoraxapertur – beteiligt sind die ersten Rippen, die kaudalen Wurzeln des Plexus brachialis, evtl. das Ganglion stellatum, die Wirbelsäule, die Subklaviagefäße.

  • Das Leitsymptom ist der Schulterschmerz. Da sich die Ersttherapie gegen eine vermutete Osteoarthropathie richtet, wird die korrekte Diagnose häufig spät gestellt.

  • Der Erfolg der onkologischen Behandlung hängt von der genauen Einschätzung der Tumorausbreitung ab: Neben den Standarduntersuchungen (CT-Thorax, PET-CT, MRT-Schädel) sollen eine invasive Untersuchung des Mediastinums und eine MRT der oberen Thoraxapertur angeschlossen werden.

    • Standarduntersuchungen:

      • CT-Thorax

      • PET-CT

      • MRT-Schädel

    • invasive Untersuchung des Mediastinums:

      • EBUS-Bronchoskopie (EBUS = endobronchial ultrasound) mit transbronchialer Nadelaspiration (TBNA)

      • Mediastinoskopie

  • Standardbehandlung des potentiell resektablen Pancoast-Tumors ist eine trimodale Therapie mit kombinierter Chemoradiotherapie und erweiterter Chirurgie.

  • Bei inoperabler, nicht metastatischer Erkrankung stellt die definitive Chemoradiotherapie die beste palliative Option dar. Falls nicht zumutbar, kommt die alleinige Bestrahlung in Betracht.

Schlüsselwörter

Lungenkarzinom - Chemotherapie - Radiotherapie - Chirurgie

Key words

lung cancer - chemotherapy - radiotherapy - surgery
 

  • Literatur

  • 1 Pancoast HK. Importance of careful roentgen-ray investigations of apical chest tumors. JAMA 1924; 83: 1407-1411
    CrossrefGoogle Scholar
  • 2 Detterbeck FC. Changes in the treatment of Pancoast tumors. Ann Thorac Surg 2003; 75: 1990-1997
    CrossrefPubMedGoogle Scholar
  • 3 Arcasoy SM, Jett JR. Superior pulmonary sulcus tumors and Pancoastʼs syndrome. N Engl J Med 1997; 337: 1370-1376
    CrossrefPubMedGoogle Scholar
  • 4 GEKID – Gesellschaft der epidemiologischen Krebsregister in Deutschland e.V. in Zusammenarbeit mit dem Robert Koch Institut. Krebs in Deutschland, Häufigkeiten und Trends, 5. Ausgabe. Saarbrücken: GEKID; 2006
    Google Scholar
  • 5 Rusch VW. Management of Pancoast tumors. Lancet Oncol 2006; 7: 997-1005
    CrossrefPubMedGoogle Scholar
  • 6 Rami-Porta R. et al. The IASLC Lung Cancer Staging Project: Proposals for the revisions of the T descriptors in the forthcoming eighth edition of the TNM classification for lung cancer. J Thorac Oncol 2015; 10: 990-1003
    CrossrefPubMedGoogle Scholar
  • 7 Marulli G, Battistella L, Mammana M. et al. Superior sulcus tumors (Pancoast tumors). Ann Transl Med 2016; 4: 239-252
    CrossrefPubMedGoogle Scholar
  • 8 Ginsberg RJ, Martini N, Zaman M. et al. Influence of surgical resection and brachytherapy in the management of superior sulcus tumor. Ann Thorac Surg 1994; 57: 1440-1445
    CrossrefPubMedGoogle Scholar
  • 9 Chardack WM, MacCallum JD. Pancoast tumor. Five year survival without recurrence or metastasis following radical resection and postoperative irradiation. J Thorac Surg 1956; 31: 535-542
    PubMedGoogle Scholar
  • 10 Shaw RR, Paulson DL, Kee JL. Treatment of the superior sulcus tumor by irradiation followed by resection. Ann Surg 1961; 154: 29-40
    CrossrefPubMedGoogle Scholar
  • 11 Rusch VW, Parekh KR, Leon L. et al. Factors determining outcome after surgical resection of T3 and T4 lung cancers of the superior sulcus. J Thorac Cardiovasc Surg 2000; 119: 1147-1153
    CrossrefPubMedGoogle Scholar
  • 12 Dartevelle P, Chapelier AR, Macchiarini P. et al. Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet. J Thorac Cardiovasc Surg 1993; 105: 1025-1034
    CrossrefPubMedGoogle Scholar
  • 13 Grunenwald D, Spaggiari L. Transmanubrial osteomuscular sparing approach for apical chest tumors. Ann Thorac Surg 1997; 63: 563-566
    CrossrefPubMedGoogle Scholar
  • 14 Masaoka A, Ito Y, Yasumitsu T. Anterior approach for tumor of the superior sulcus. J Thorac Cardiovasc Surg 1979; 78: 413-415
    CrossrefPubMedGoogle Scholar
  • 15 Sundaresan N, Hilaris BS, Martini N. The combined neurosurgical-thoracic management of superior sulcus tumors. J Clin Oncol 1987; 5: 1739-1745
    CrossrefPubMedGoogle Scholar
  • 16 Gandhi S, Walsh GL, Komaki R. et al. A multidisciplinary surgical approach to superior sulcus tumors with vertebral invasion. Ann Thorac Surg 1999; 68: 1778-1784
    CrossrefPubMedGoogle Scholar
  • 17 York JE, Walsh GL, Lang FF. et al. Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors. J Neurosurg 1999; 91: 74-80
    CrossrefPubMedGoogle Scholar
  • 18 Mazel C, Grunenwald D, Laudrin P. et al. Radical excision in the management of thoracic and cervicothoracic tumors involving the spine: results in a series of 36 cases. Spine 2003; 28: 782-792
    PubMedGoogle Scholar
  • 19 Komaki R, Derus SB, Perez-Tamayo C. et al. Brain metastasis in patients with superior sulcus tumors. Cancer 1987; 59: 1649-1653
    CrossrefPubMedGoogle Scholar
  • 20 Rusch VW, Giroux DJ, Kraut MJ. et al. Induction chemoradiation and surgical resection for superior sulcus non-small-cell lung carcinomas: long-term results of Southwest Oncology Group Trial 9416 (Intergroup Trial 0160). J Clin Oncol 2007; 25: 313-318
    CrossrefPubMedGoogle Scholar
  • 21 Marra A, Eberhardt W, Pöttgen C. et al. Induction chemotherapy, concurrent chemoradiation and surgery for Pancoast tumour. Eur Respir J 2007; 29: 117-126
    PubMedGoogle Scholar
  • 22 Kunitoh H, Kato H, Tsuboi M. et al. Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. J Clin Oncol 2008; 26: 644-649
    CrossrefPubMedGoogle Scholar
  • 23 Kernstine KH, Moon J, Kraut MJ. et al. Trimodality therapy for superior sulcus non-small cell lung cancer: Southwest Oncology Group-Intergroup Trial S0220. Ann Thorac Surg 2014; 98: 402-410
    CrossrefPubMedGoogle Scholar
  • 24 Martínez-Monge R, Herreros J, Aristu JJ. et al. Combined treatment in superior sulcus tumors. Am J Clin Oncol 1994; 1: 317-322
    Google Scholar
  • 25 Attar S, Krasna MJ, Sonett JR. et al. Superior sulcus (Pancoast) tumor: experience with 105 patients. Ann Thorac Surg 1998; 66: 193-198
    CrossrefPubMedGoogle Scholar
  • 26 Wright CD, Menard MT, Wain JC. et al. Induction chemoradiation compared with induction radiation for lung cancer involving the superior sulcus. Ann Thorac Surg 2002; 73: 1541-1544
    CrossrefPubMedGoogle Scholar
  • 27 Kwong KF, Edelman MJ, Suntharalingam M. et al. High-dose radiotherapy in trimodality treatment of Pancoast tumors results in high pathologic complete response rates and excellent long-term survivial. J Thorac Cardiovasc Surg 2005; 129: 1250-1257
    CrossrefPubMedGoogle Scholar
  • 28 Goldberg M, Gupta D, Sasson AR. et al. The surgical management of superior sulcus tumors: a retrospective review with long-term follow-up. Ann Thorac Surg 2005; 79: 1174-1179
    CrossrefPubMedGoogle Scholar
  • 29 Pourel N, Santelmo N, Naafa N. et al. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response. Eur J Cardiothorac Surg 2008; 33: 829-836
    CrossrefPubMedGoogle Scholar
  • 30 Fischer S, Darling G, Pierre AF. et al. Induction chemoradiation therapy followed by surgical resection for non-small cell lung cancer (NSCLC) invading the thoracic inlet. Eur J Cardiothorac Surg 2008; 33: 1129-1134
    CrossrefPubMedGoogle Scholar
  • 31 Kappers I, van Sandick JW, Burgers JA. et al. Results of combined modality treatment in patients with non-small cell lung cancer of the superior sulcus and the rationale for surgical resection. Eur J Cardiothorac Surg 2009; 36: 741-746
    CrossrefPubMedGoogle Scholar
  • 32 Gomez DR, Cox JD, Roth JA. et al. A prospective phase 2 study of surgery followed by chemotherapy and radiation for superior sulcus tumors. Cancer 2012; 118: 444-451
    CrossrefPubMedGoogle Scholar
  • 33 Paulson DL. Superior sulcus tumors. N Y State J Med 1971; 1: 2050-2057
    Google Scholar
  • 34 Tatsumura T, Sato H, Mori A. et al. A new surgical approach to apical segment lung diseases, including carcinomas and inflammatory diseases. J Thorac Cardiovasc Surg 1994; 107: 32-36
    CrossrefPubMedGoogle Scholar
  • 35 Dartevelle P, Chapelier AR, Macchiarini P. et al. Anterior transcervical-thoracic approach for radical resection of lung tumors invading the thoracic inlet. J Thorac Cardiovasc Surg 1993; 105: 1025-1034
    CrossrefPubMedGoogle Scholar
  • 36 Grunenwald D, Spaggiari L. Transmanubrial osteomuscular sparing approach for apical chest tumors. Ann Thorac Surg 1997; 63: 563-566
    CrossrefPubMedGoogle Scholar
  • 37 Spaggiari L, Pastorino U. Transmanubrial approach with antero-lateral thoracotomy for apical chest tumor. Ann Thorac Surg 1999; 68: 590-593
    CrossrefPubMedGoogle Scholar
  • 38 Horn M, Hoppert T, Günther A. et al. Technische Vorteile des transmanubrialen Zugangs nach Grunenwald zur Resektion von Pancoast-Tumoren. Zentralbl Chir 2017; 142 (S01): S67-S112
    Google Scholar
  • 39 Bains MS, Ginsberg RJ, Jones 2nd WG. et al. The clamshell incision: an improved approach to bilateral pulmonary and mediastinal tumor. Ann Thorac Surg 1994; 58: 30-32
    CrossrefPubMedGoogle Scholar
  • 40 Masaoka A, Ito Y, Yasumitsu T. Anterior approach for tumor of the superior sulcus. J Thorac Cardiovasc Surg 1979; 78: 413-415
    CrossrefPubMedGoogle Scholar
  • 41 Nakajima T, Watanabe A, Nakazawa J. et al. Transmanubrial approach with video-assisted thoracoscopic surgery for left superior sulcus tumour with dense adhesion after replacement of descending thoracic aorta. Interact Cardiovasc Thorac Surg 2012; 14: 906-908
    CrossrefPubMedGoogle Scholar
  • 42 Caronia FP, Fiorelli A, Ruffini E. et al. A comparative analysis of Pancoast tumour resection performed via videoassisted thoracic surgery versus standard open approaches. Interact Cardiovasc Thorac Surg 2014; 19: 426-435
    CrossrefPubMedGoogle Scholar
  • 43 Komaki R, Roth JA, Walsh GL. et al. Outcome predictors for 143 patients with superior sulcus tumors treated by multimodality approach at the University of Texas MD Anderson Cancer Center. Int J Radiat Oncol Biol Phys 2000; 48: 347-354
    PubMedGoogle Scholar
  • 44 Goeckenjan G, Sitter H, Thomas M. et al. Prävention, Diagnostik, Therapie und Nachsorge des Lungenkarzinoms. Pneumologie 2010; 64 (Suppl. 02) e1-e164 doi:10.1055/s-0029-1243837
    Article in Thieme ConnectPubMedGoogle Scholar
  • 45 Kozower BD, Larner JM, Detterbeck FC. et al. Special treatment issues in non-small cell lung cancer. Chest 2013; 143 (Suppl.) e369S-e399S
    CrossrefPubMedGoogle Scholar
  • 46 NCCN Clinical Practice Guidelines in Oncology. Non-small cell lung cancer. Version 9.2017–28. September 2017. Im Internet: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp Stand: 01.10.2017
    PubMedGoogle Scholar